Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP4OX in trauma patients with hemorrhagic shock
NCT01004198Phase 2Completed
- Sponsor
- Sangart
- Start
- Dec 2009
- Primary completion
- Jun 2010
- Countries
- 4
01
Overview
A Phase 2 trial of Hemospan in hemorrhagic shock, lactic acidosis, sponsored by Sangart. Started Dec 2009; status: completed.
02
Drugs
Hemospan
03
Conditions
hemorrhagic shocklactic acidosis
Beyond the preview
Go deeper on NCT01004198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01004198.